SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.810.0%Nov 24 3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16936)6/28/2004 11:45:51 PM
From: Bluegreen   of 17367
 
George, check out the poster presentations that start on page 12. Looks like Raptiva is becoming a GLOBAL Biological treatment alternative that is MUCH SAFER. Amazing that this is a Canadian meeting. Btw, no matter where you live the clinician is ALWAYS an ADVOCATE for the patient. Therefore, don't be surprised to see most moderate to severe psoriasis patients in Europe become suddenly unresponsive or having intolerable side effects to the old, toxic, cheaper treatments. Enjoy.>>>>>>>>http://www.dermatology.ca/commongraphics/agm2004/program_reg.pdf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext